메뉴 건너뛰기




Volumn 39, Issue 1, 2011, Pages 184-186

High permeability dialysis membrane allows effective removal of myoglobin in acute kidney injury resulting from rhabdomyolysis

Author keywords

acute kidney injury; dialysis; myoglobin; polysulphone high flux dialyzer; rhabdomyolysis

Indexed keywords

CREATININE; MYOGLOBIN; POLYSULFONE; UREA;

EID: 78651240833     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181feb7f0     Document Type: Article
Times cited : (50)

References (12)
  • 1
    • 15844385432 scopus 로고    scopus 로고
    • Bench-to-bedside review: Rhabdomyolysis- An overview for clinicians
    • Huerta-Alardin AL, Varon J, Marik PE: Bench-to-bedside review: Rhabdomyolysis- An overview for clinicians. Crit Care 2005;9:158-169
    • (2005) Crit Care , vol.9 , pp. 158-169
    • Huerta-Alardin, A.L.1    Varon, J.2    Marik, P.E.3
  • 2
    • 67649644926 scopus 로고    scopus 로고
    • Rhabdomyolysis and acute kidney injury
    • Bosch X, Poch E, Grau JM: Rhabdomyolysis and acute kidney injury. N Engl J Med 2009;361:62-72
    • (2009) N Engl J Med , vol.361 , pp. 62-72
    • Bosch, X.1    Poch, E.2    Grau, J.M.3
  • 3
    • 67650501124 scopus 로고    scopus 로고
    • Procedure- related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection-Role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system
    • Kielstein JT, Hesse G, Bahr MJ, et al: Procedure- related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection-Role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system. Crit Care Med 2009;37:1483-1485
    • (2009) Crit Care Med , vol.37 , pp. 1483-1485
    • Kielstein, J.T.1    Hesse, G.2    Bahr, M.J.3
  • 4
    • 56949095515 scopus 로고    scopus 로고
    • The syndrome of rhabdomyolysis: Complications and treatment
    • Chatzizisis YS, Misirli G, Hatzitolios AI, et al: The syndrome of rhabdomyolysis: Complications and treatment. Eur J Intern Med 2008;19:568-574
    • (2008) Eur J Intern Med , vol.19 , pp. 568-574
    • Chatzizisis, Y.S.1    Misirli, G.2    Hatzitolios, A.I.3
  • 5
    • 33644819144 scopus 로고    scopus 로고
    • Technology Insight: Treatment of renal failure in the intensive care unit with extended dialysis
    • Fliser D, Kielstein JT: Technology Insight: Treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol 2006;2:32-39
    • (2006) Nat Clin Pract Nephrol , vol.2 , pp. 32-39
    • Fliser, D.1    Kielstein, J.T.2
  • 6
    • 29744454526 scopus 로고    scopus 로고
    • Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis
    • Kielstein JT, Czock D, Schopke T, et al: Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med 2006;34: 51-56
    • (2006) Crit Care Med , vol.34 , pp. 51-56
    • Kielstein, J.T.1    Czock, D.2    Schopke, T.3
  • 7
    • 34249919929 scopus 로고
    • Myoglobin clearance during acute continuous hemodiafiltration
    • Bellomo R, Daskalakis M, Parkin G, et al: Myoglobin clearance during acute continuous hemodiafiltration. Intensive Care Med 1991;17:509
    • (1991) Intensive Care Med , vol.17 , pp. 509
    • Bellomo, R.1    Daskalakis, M.2    Parkin, G.3
  • 8
    • 0031864977 scopus 로고    scopus 로고
    • Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis
    • Nicolau D, Feng YS, Wu AH, et al: Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis. Int J Artif Organs 1998;21:205-209
    • (1998) Int J Artif Organs , vol.21 , pp. 205-209
    • Nicolau, D.1    Feng, Y.S.2    Wu, A.H.3
  • 9
    • 0032718336 scopus 로고    scopus 로고
    • Myoglobin clearance and removal during continuous venovenous hemofiltration
    • Amyot SL, Leblanc M, Thibeault Y, et al: Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med 1999;25:1169-1172
    • (1999) Intensive Care Med , vol.25 , pp. 1169-1172
    • Amyot, S.L.1    Leblanc, M.2    Thibeault, Y.3
  • 10
    • 15844423587 scopus 로고    scopus 로고
    • Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: A case report
    • Naka T, Jones D, Baldwin I, et al: Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: A case report. Crit Care 2005;9:R90-R95
    • (2005) Crit Care , vol.9
    • Naka, T.1    Jones, D.2    Baldwin, I.3
  • 11
    • 0034982120 scopus 로고    scopus 로고
    • Continuous veno-venous hemofiltration for the immediate management of massive rhabdomyolysis after fulminant malignant hyperthermia in a bodybuilder
    • Schenk MR, Beck DH, Nolte M, et al: Continuous veno-venous hemofiltration for the immediate management of massive rhabdomyolysis after fulminant malignant hyperthermia in a bodybuilder. Anesthesiology 2001;94:1139-1141
    • (2001) Anesthesiology , vol.94 , pp. 1139-1141
    • Schenk, M.R.1    Beck, D.H.2    Nolte, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.